Correction: Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma. BMJ Publishing Group.
Chicago Style (17th ed.) CitationCorrection: Multicenter, Single-arm, Phase II Trial of Camrelizumab and Chemotherapy as Neoadjuvant Treatment for Locally Advanced Esophageal Squamous Cell Carcinoma. BMJ Publishing Group.
MLA (9th ed.) CitationCorrection: Multicenter, Single-arm, Phase II Trial of Camrelizumab and Chemotherapy as Neoadjuvant Treatment for Locally Advanced Esophageal Squamous Cell Carcinoma. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.